Tagged with R

Argentina SA Baxter Do you think this is a good moment for the Argentinean pharmaceutical industry to have international exposure? Indeed it is attractive, but we should keep the long term objectives on perspective. It is a stable and interesting market for multinational companies, as long as they can grasp the dynamics of…

Bayer Thailand Mr. Ammelburg of Roche described Thailand as a very difficult and different market and according to PReMA figures there was only 2 percent growth last year. Nevertheless, global projections rank Thailand as 12th among emerging countries in pharma and anticipate Thailand becoming the eighth largest economy and market by 2016.…

Laboratorios Richmond What have been the recent major milestones for Richmond? One of the milestones for Laboratorios Richmond was to have developed the first branded oncological generic in the world. For Laboratorios Richmond to be developing combinations of different molecules from different originator laboratories is very important as well, as it provides…

Biogen Idec Argentina Biogen Idec’s arrival in Argentina has been very recent. Could you explain to our readers why the time was right to take back your licences and to set up in Argentina? Biogen Idec has a worldwide expansion strategy. Two years ago, the company decided to establish its own affiliates in…

CETIFARMA The Mexican government has been fairly pro-active about promoting good practice such as the new drug registration process that helped eliminate drugs from the Mexican market that didn’t fulfill regulatory therapeutic efficiency. In this context, what is left to do for CETIFARMA? In my opinion when the authorities take a…

Sayenko Kharenko If you could provide our readers with your philosophy when you founded Sayenko Kharenko in 2004. What were the market needs that were perhaps missing that you identified and wanted to address? If you look at the top 5 law firms in Ukraine, Sayenko Kharenko definitely is not the oldest…

Thai Pharmaceutical Manufacturers Association TPMA is the main association bringing together the local manufacturers in Thailand. What do you consider to have been the main milestones and achievements since your inception? We haven’t reached any milestones yet. Our first milestone will be to open and free the pharmaceutical market in Thailand by breaking the…

PREMA Thailand PReMa was established in 2004 after a period of transformation to represent the growing role of its members, research-based companies. To begin with, could you explain us the main milestones and achievements of the organization? PReMA has been present in Thailand for 42 years. The association only changed and took…

Laboratórios Bernabó Laboratorios Bernabó es una de las empresas farmacéuticas más distinguidos de toda la historia de la Argentina, con más de 70 años en el mercado. ¿Cómo ha cambiado la visión de Bernabó a través de la historia, lugar donde está hoy, y qué papel ha desempeñado en esta evolución? Comence…

Roche Argentina Argentina was home to Roche´s first Latin American subsidiary. Today, how important is Argentina for Roche worldwide? Argentina will become this year the third affiliate –after Brazil and Mexico-in terms of sales in Latin America, which of course makes it an important country for the Roche business, from a regional…

Novo Nordisk Argentina Novo Nordisk’s largest insulin production facility outside of Denmark is in Latin America, in Brazil. Can you explain the strategic importance of this for Argentina, and how Novo Nordisk is structured here in the country? Here in Argentina Novo Nordisk has an affiliate focused on commercial activities, clinical research and…

Fundacion ExportAR Fundacion Export.Ar was formed in 1993. What was the vision behind the foundation of the company and why was it formed at that specific time? Argentina understood that the country had to create an agency to promote exports. We were a closed economy, and Argentina was trying to become an…